ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation. Magri F, Capelli V, Gaiti M, Villani L, Zerbini F, La Manna L, Rotondi M, Chiovato L. Endocrine. 2015 Jun;49(2):429-35. doi: 10.1007/s12020-014-0457-x. Epub 2014 Oct 22.
Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling. Eterno V, Zambelli A, Pavesi L, Villani L, Zanini V, Petrolo G, Manera S, Tuscano A, Amato A. Oncotarget. 2014 Feb 15;5(3):613-33.
Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes. Rotondi M, Coperchini F, Sideri R, Groppelli G, de Martinis L, Villani L, Pignatti P, Magri F, Chiovato L. J Interferon Cytokine Res. 2013 Sep;33(9):508-13. doi: 10.1089/jir.2012.0080. Epub 2013 May 15.
Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. Magri F, Capelli V, Rotondi M, Leporati P, La Manna L, Ruggiero R, Malovini A, Bellazzi R, Villani L, Chiovato L. Endocr Relat Cancer. 2012 Jun 18;19(4):463-71. doi: 10.1530/ERC-11-0389. Print 2012 Aug
Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias. Denegri M, Avelino-Cruz JE, Boncompagni S, De Simone SA, Auricchio A, Villani L, Volpe P, Protasi F, Napolitano C, Priori SG. Circ Res. 2012 Mar 2;110(5):663-8. doi: 10.1161/CIRCRESAHA.111.263939. Epub 2012 Jan 31.
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Mello-Grand M, Singh V, Ghimenti C, Scatolini M, Regolo L, Grosso E, Zambelli A, Da Prada GA, Villani L, Fregoni V, Baiardi P, Marsoni S, Miller WR, Costa A, Chiorino G. Breast Cancer Res Treat. 2010 Jun;121(2):399-411. doi: 10.1007/s10549-010-0887-y. Epub 2010 Apr 29.
Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Rizzi N, Liu N, Napolitano C, Nori A, Turcato F, Colombi B, Bicciato S, Arcelli D, Spedito A, Scelsi M, Villani L, Esposito G, Boncompagni S, Protasi F, Volpe P, Priori SG. Circ Res. 2008 Aug 1;103(3):298-306. doi: 10.1161/CIRCRESAHA.108.171660. Epub 2008 Jun 26.
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2. Varchetta S, Gibelli N, Oliviero B, Nardini E, Gennari R, Gatti G, Silva LS, Villani L, Tagliabue E, Ménard S, Costa A, Fagnoni FF. Cancer Res. 2007 Dec 15;67(24):11991-9
An unusual parasitological finding in a subcutaneous mammary nodule. Pampiglione S, Orihel TC, Gustinelli A, Gatzemeier W, Villani L. Pathol Res Pract. 2005;201(6):475-8.
Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.Cerrone M, Colombi B, Santoro M, di Barletta MR, Scelsi M, Villani L, Napolitano C, Priori SG. Circ Res. 2005 May 27;96(10):e77-82. Epub 2005 May 12.
